Avandia fears knock hole in GSK's profits
Thursday 24 April 2008
GlaxoSmithKline, the world's No 2 pharmaceuticals firm, announced disappointing first-quarter results yesterday, with profits down on the same period last year, as sales of Avandia continued to fall. However, most analysts were relieved that the figures were not worse and predicted a "period of stability".
GSK shares have fallen 26 per cent since the start of the year, mostly on the back of a profits warning the group issued in February. Pre-tax profits for the first three months to March fell to £1.87bn from £2.14bn last year. Underlying profits were down 9 per cent to £2.05bn.
Much of the blame lies with lower sales of the company's once blockbuster diabetes treatment Avandia. The safety of the drug was questioned in the New England Medical Journal last May, which led to a collapse of sales in the US. Despite the headline numbers, analysts cautiously welcomed yesterday's numbers, saying they were in line with expectations but that the real test would come when like-for-like sales of Avandia are known. Sales of Avandia fell 56 per cent compared with the first quarter last year.
"Avandia was a black swan event and the damage is done," said Peter Cartwright, an analyst at Evolution. "They have pretty much stabilised now and most of the numbers out today are as we expected, or slightly better."
Julian Heslop, the group's chief finance officer, said that sales of Avandia had stabilised in the US in the last four to six weeks and pointed to the company's performance in vaccines and consumer healthcare as highlights. The vaccine arm of the business grew by 10 per cent to £436m, while the consumer healthcare division was up 8 per cent to £893m.
A number of the group's patents end this year, but Jeremy Batstone-Carr of analysts Charles Stanley said the company has 157 products in the pipeline.
GSK shares were up 18p to 1,120p yesterday.
- 1 Nigel Farage: Me vs Russell Brand on Question Time – he's got the chest hair but where are his ideas?
- 2 Harry Potter fans can apply to the Hogwarts-inspired College of Wizardry
- 3 Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
- 4 Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
- 5 Orange Wednesdays are no more
Weather bomb in pictures: Storms cuts power for tens of thousands – and snow is on the way
Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
Russell Brand was rendered speechless on Question Time by this man
Fury at Airbus after it hints the super-jumbo may be mothballed
Disgruntled RBS worker writes hilarious open letter to Russell Brand after anti-capitalist publicity stunt leaves him hungry
Nigel Farage defends Kerry Smith 'ch***y' comment: 'If you are going for a Chinese, what do you say you’re going for?'
Nigel Farage's approval rating hits 'record low' as popularity suffers in wake of Ukip sex scandal
Pakistan school attack live: Taliban kill at least 132 children in 'horrifying' massacre
Sony hack: Angelina Jolie branded 'seriously out of her mind' in further embarrassing leaked email saga
Panic Saturday: 13 million Britons spend £1.2bn – while 13 million others across the country live in poverty unable to afford food
iJobs Money & Business
£20000 - £25000 per annum + OTE £40,000 + Car + Pension: SThree: SThree are a ...
£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...
£20000 - £25000 per annum + OTE £35000: SThree: SThree are a global FTSE 250 b...
£20000 - £25000 per annum + OTE £35K - £45K: SThree: SThree Group have been we...